Gastrointestinal and Hepatic Complications of Sickle Cell Disease

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 6, 2010, Pages 483-489

  Ebert, Ellen C ^a   Nagar, Michael ^a   Hagspiel, Klaus D ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Abdominal Pain; Gallstones; Liver Disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FERRITIN; HEMOGLOBIN S; HYDROXYUREA; IRON; LACTATE DEHYDROGENASE; TECHNETIUM SULFUR COLLOID TC 99M;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT DILATATION; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLELITHIASIS; CHRONIC LIVER DISEASE; COMMON BILE DUCT; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE; FERRITIN BLOOD LEVEL; GALLSTONE; HEMOSIDEROSIS; HEPATITIS; HEPATITIS B; HUMAN; HYPERBILIRUBINEMIA; INTESTINE ISCHEMIA; INTRAHEPATIC CHOLESTASIS; IRON STORAGE; KUPFFER CELL; LABORATORY DIAGNOSIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER ABSCESS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER SCINTISCANNING; LIVER VENOOCCLUSIVE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; SICKLE CELL ANEMIA; SPLEEN; SPLEEN INFARCTION; STEM CELL TRANSPLANTATION; ZINC DEFICIENCY;

ANEMIA; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BILIRUBIN; BLOOD TRANSFUSION; GALLSTONES; HUMANS; HYDROXYUREA; HYPERBILIRUBINEMIA; INFARCTION; IRON CHELATING AGENTS; L-LACTATE DEHYDROGENASE; LIVER DISEASES; STEM CELL TRANSPLANTATION;

EID: 77952741296     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.02.016     Document Type: Review

References (98)

1. Harmening D.M. Clinical hematology and fundamentals of hemostasis. 5th ed. (2009), FA Davis Co, Philadelphia 209-214
2. Braunwald E., Fauci A.S., Kasper D.L., et al. Harrison's principles of internal medicine. 15th ed. (2001), McGraw-Hill Medical Publishing Division, New York, NY 669
3. Yeung K.-Y., and Lessin L.S. Splenic infarction in sickle cell-hemoglobin C disease. Arch Intern Med 136 (1976) 905-911
4. King D.T., Lindstrom R.R., State D., et al. Unusual cause of acute abdomen: sickle cell trait and nonhypoxic splenic infarction. JAMA 238 (1977) 2173-2174
5. Madani G., Papadopoulou A.M., Holloway B., et al. The radiological manifestations of sickle cell disease. Clin Radiology 62 (2007) 528-538
6. Roshkow J.E., and Sanders L.M. Acute splenic sequestration crisis in two adults with sickle cell disease: US, CT, and MR imaging findings. Radiology 177 (1990) 723-725
7. Koskinas J., Manesis E.K., Zacharakis G.H., et al. Liver involvement in acute vaso-occlusive crisis of sickle cell disease: prevalence and predisposing factors. Scand J Gastroenterol 42 (2007) 499-507
8. Bauer T.W., Moore G.W., and Hutchins G.M. The liver in sickle cell disease: a clinicopathologic study of 70 patients. Am J Med 69 (1980) 833-837
9. Mengel C.E., Schauble J.F., and Hammond C.B. Infarct-necrosis of the liver in a patient with S-A hemoglobin. Arch Intern Med 111 (1963) 93-98
10. Fishbone G., Nunez Jr. D., Leon R., et al. Massive splenic infarction in sickle cell-hemoglobin C disease: angiographic findings. AJR 129 (1977) 927-928
11. Johnson C.S., Omata M., Tong M.J., et al. Liver involvement in sickle cell disease. Medicine 64 (1985) 349-356
12. Schubert T.T. Hepatobiliary system in sickle cell disease. Gastroenterology 90 (1986) 2013-2021
13. Rosenblate H.J., Eisenstein R., and Holmes A.W. The liver in sickle cell anemia: a clinical-pathologic study. Arch Pathol 90 (1970) 235-245
14. Hatton C.S.R., Bunch C., and Weatherall D.J. Hepatic sequestration in sickle cell anaemia. Br Med J 290 (1985) 744-745
15. Hernandez P., Dorticos E., Espinosa E., et al. Clinical features of hepatic sequestration in sickle cell anaemia. Haematologia 22 (1989) 169-174
16. Lee E.S., and Chu P.C. Reverse sequestration in a case of sickle crisis. Postgrad Med J 72 (1996) 487-488
17. Shao S.H., and Orringer E.P. Sickle cell intrahepatic cholestasis: approach to a difficult problem. Am J Gastroenterol 90 (1995) 2048-2050
18. Owen D.M., Aldridge J.E., and Thompson R.B. An unusual hepatic sequela of sickle cell anemia: a report of five cases. Am J Med Sci 249 (1965) 175-185
19. Garcia-Arias M.B., Rodriguez-Galindo C., Hoffer F.A., et al. Pyogenic hepatic abscess after percutaneous liver biopsy in a patient with sickle cell disease. J Ped Hematol/Oncol 27 (2005) 103-105
20. Shulman S.T., and Beem M.O. An unique presentation of sickle cell disease: pyogenic hepatic abscess. Pediatrics 47 (1971) 1019-1022
21. Robins-Browne R.M., and Prpic J.K. Desferrioxamine and systemic yersiniosis. Lancet 2 (1983) 1372
22. Sheehy T.W. Sickle cell hepatopathy. South Med J 70 (1977) 533-538
23. DeVault K.R., Friedman L.S., Westerberg S., et al. Hepatitis C in sickle cell anemia. J Clin Gastroenterol 18 (1994) 206-209
24. Mok Q., Underhill G., Wonke B., et al. Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease. Arch Dis Child 64 (1989) 535-540
25. Middletown J.P., and Wolper J.C. Hepatic biloma complicating sickle cell disease: a case report and a review of the literature. Gastroenterology 86 (1984) 743-744
26. Saltzman J.R., and Johnston D.E. Sickle cell crisis and cocaine hepatotoxicity. Am J Gastroenterol 87 (1992) 1661-1663
27. Sty R.J. Ultrasonography: hepatic vein thrombosis in sickle cell anemia. Am J Pediatr Hematol-Oncol 4 (1982) 213-215
28. Arnold K.E., Char G., and Serjeant G.R. Portal vein thrombosis in a child with homozygous sickle cell disease. West India Med J 42 (1993) 27-28
29. Berry P.A., Cross T.J., Thein S.L., et al. Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clin Gastroenterol Hepatol 5 (2007) 1469-1476
30. Darbari D.S., Kple-Faget P., Kwagyan J., et al. Circumstances of death in adult sickle cell disease patients. Am J Hematol 81 (2006) 858-863
31. Ayyub M.A., El-Moursy S.A., Khazindar A.M., et al. Successful treatment of chronic hepatitis C virus infection with peginterferon alpha-2a and ribavirin in patients with sickle cell disease. Saudi Med J 30 (2009) 712-716
32. Ancel D., Amiot X., Chaslin-Ferbus D., et al. Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin. Eur J Gastroenterol Hepatol 21 (2009) 726-729
33. Telfer P.T., Garson J.A., Whitby K., et al. Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients. Br J Haematol 98 (1997) 850-855
34. Markowitz R.I., Harcke H.T., Ritchie W.G., et al. Focal nodular hyperplasia of the liver in a child with sickle cell anemia. AJR 134 (1980) 594-597
35. Al-Mukhaizeem K.A., Lamoureux E., Rosenberg A., et al. Nodular regenerative hyperplasia of the liver and focal global glomerulosclerosis associated with sickle cell anemia. Dig Dis Sci 47 (2002) 443-447
36. Yuzbasiyan-Gurkan V.A., Brewer G.J., Vander A.J., et al. Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia. Am J Hematol 31 (1989) 87-90
37. Silliman C.C., Peterson V.M., Mellman D.L., et al. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship. J Lab Clin Med 122 (1993) 48-54
38. Prasad A.S., Rabbani P., and Warth J.A. Effect of zinc on hyperammonemia in sickle cell anemia subjects. Am J Hematol 7 (1979) 323-327
39. Prasad A.S., Beck F.W., Kaplan J., et al. Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease. Am J Hematol 61 (1999) 194-202
40. Bond L.R., Hatty S.R., Horn M.E.C., et al. Gallstones in sickle cell disease in the United Kingdom. Br Med J 295 (1987) 234-236
41. Rennels M.B., Dunne M.G., Grossman N.J., et al. Cholelithiasis in patients with major sickle hemoglobinopathies. Am J Dis Child 138 (1984) 66-67
42. Sarnaik S., Slovis T.L., Corbett D.P., et al. Incidence of cholelithiasis in sickle cell anemia using the ultrasonic gray-scale technique. J Pediatr 96 (1980) 1005
43. Rao V.M., Mapp E.M., and Wechsler R.J. Radiology of the gastrointestinal tract in sickle cell anemia. Semin Roentgenol 22 (1987) 195-204
44. Stephens C.G., and Scott R.B. Cholelithiasis in sickle cell anemia: surgical or medical management. Arch Intern Med 140 (1980) 648-651
45. Ware R.E., Schultz W.H., Filston H.C., et al. Diagnosis and management of common bile duct stones in patients with sickle hemoglobinopathies. J Pediatric Surg 27 (1992) 572-575
46. Ware R., Filston H.C., Schultz W.H., et al. Elective cholecystectomy in children with sickle hemoglobinopathies. Ann Surg 208 (1988) 17-22
47. Gholson C.F., Grier J.F., Ibach M.B., et al. Sequential endoscopic/laparoscopic management of sickle hemoglobinopathy-associated cholelithiasis and suspected choledocholithiasis. South Med J 88 (1995) 1131-1135
48. Hillaire S., Gardin C., Attar A., et al. Cholangiopathy and intrahepatic stones in sickle cell disease: coincidence or ischemic cholangiopathy?. Am J Gastroenterol 95 (2000) 300-301
49. Charlotte F., Bachir D., Nenert M., et al. Vascular lesions of the liver in sickle cell disease: a clinicopathological study in 26 living patients. Arch Pathol Lab Med 119 (1995) 46-52
50. Vichinsky E.P., Haberkern C.M., Neumayr L., et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 333 (1995) 206-213
51. Curro G., Meo A., Ippolito D., et al. Asymptomatic cholelithiasis in children with sickle cell disease: early or delayed cholecystectomy?. Ann Surg 245 (2007) 126-129
52. Suell M.N., Horton T.M., Dishop M.K., et al. Outcomes for children with gallbladder abnormalities and sickle cell disease. J Pediatr 145 (2004) 617-621
53. Meshikhes A.W., Al-Abkari H.A., Al-Faraj A.A., et al. The safety of laparoscopic cholecystectomy in sickle cell disease: an update. Ann Saudi Med 18 (1998) 12-14
54. Haberkern C.M., Neumayr L.D., Orringer E.P., et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Blood 89 (1997) 1533-1542
55. Al-Mulhim A.S., Al-Mulhim F.M., and Al-Suwaiygh A.A. The role of laparoscopic cholecystectomy in the management of acute cholecystitis in patients with sickle cell disease. Am J Surg 183 (2002) 668-672
56. Rutledge R., Croom R.D., Davis J.W., et al. Cholelithiasis in sickle cell anemia: surgical considerations. South Med J 79 (1886) 28-30
57. Manno C.S., Cohen A.R., and Schwartz E. Sickle cell anemia and cholelithiasis. Pediatr Radiol 18 (1988) 178
58. Lee M.G., Thirumalai C.H., Terry S.I., et al. Endoscopic and gastric acid studies in homozygous sickle cell disease and upper abdominal pain. Gut 30 (1989) 569-572
59. Wosornu L., and Konotey-Ahulu. Gastric acid secretion in sickle cell anaemia. Gut 12 (1971) 197-199
60. Gage T.P., and Gagnier J.M. Ischemic colitis complicating sickle cell crisis. Gastroenterology 84 (1983) 171-174
61. Hammond T.G., and Mossesson M.W. Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease. Arch Intern Med 149 (1989) 147-148
62. Qureshi A., Lang N., and Bevan D.H. Sickle cell "girdle syndrome" progressing to ischaemic colitis and colonic perforation. Clin Lab Haematol 28 (2006) 60-62
63. Baruchel S., Delifer J.C., Sigalet D., et al. Pseudomembranous colitis in sickle cell disease responding to exchange transfusion. J Pediatr 121 (1992) 915-917
64. Heyman M.B., Lande W., Vichinsky E., et al. Elevated fasting breath hydrogen and abnormal breath tests in sickle cell disease: a preliminary report. Am J Clin Nutr 49 (1989) 654-657
65. Barrett-Connor E. Sickle cell and viral hepatitis. Ann Intern Med 69 (1968) 517-527
66. Buchanan G.R., and Glader B.E. Benign course of extreme hyperbilirubinemia in sickle cell anemia: analysis of six cases. J Pediatr 91 (1977) 21-24
67. Maddrey W.C., Cukier J.O., Maglalang A.C., et al. Hepatic bilirubin UDP-glucuronyltransferase in patients with sickle cell anemia. Gastroenterology 74 (1978) 193-195
68. Brody J.I., Ryan W.N., and Haidar M.A. Serum alkaline phosphatase isoenzymes in sickle cell anemia. JAMA 232 (1975) 738-741
69. Mohamed A.O., Jansson A., and Ronquist G. Increased activity of 5′-nucleotidase in serum in patients with sickle cell anaemia. Scand J Clin Lab Invest 53 (1993) 701-704
70. Voskaridou E., Douskou M., Terpos E., et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 126 (2004) 736-742
71. Brittenham G.M., Cohen A.R., McLaren C.E., et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol 42 (1993) 81-85
72. Harmatz P., Butensky E., Quirolo K., et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 96 (2000) 76-79
73. Brownell A., Lowson S., and Brozovic M. Serum ferritin concentration in sickle cell crisis. J Clin Pathol 39 (1986) 253-255
74. Silberstein E.B., DeLong S., and Cline J. Tc-99m diphosphonate and sulfur colloid uptake by the spleen in sickle disease: interrelationship and clinical correlates-concise communication. J Nucl Med 225 (1984) 1300-1303
75. Geola F., Kukreja S.C., and Schade S.G. Splenic sequestration with sickle cell-C disease. Arch Intern Med 138 (1978) 307-308
76. Levin T.L., Berdon W.E., Haller J.O., et al. Intrasplenic masses of "preserved" functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol 26 (1996) 646-649
77. D'Alonzo W.A., and Heyman S. Biliary scintigraphy in children with sickle cell anemia and acute abdominal pain. Fr. Pediatr Radiol 15 (1985) 395-398
78. Magid D., Fishman E.K., Charache S., et al. Abdominal pain in sickle cell disease: the role of CT. Radiology 163 (1987) 325-328
79. Magid D., Fishman E.K., and Siegelman S.S. Computed tomography of the spleen and liver in sickle cell disease. Am J Roentgenol 143 (1984) 245-249
80. Wood J.C., Enriquez C., Ghugre N., et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106 (2005) 1460-1465
81. Hernandez R.J., Sarnaik S.A., Lande I., et al. MR evaluation of liver iron overload. J Comp Assisted Tomography 12 (1988) 91-94
82. Flyer M.A., Haller J.O., and Sundaram R. Transfusional hemosiderosis in sickle cell anemia: another cause of an echogenic pancreas. Pediatr Radiol 23 (1993) 140-142
83. Omata M., Johnson C.S., Tong M., et al. Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci 31 (1986) 247-256
84. Zakaria N., Knisely A., Portmann B., et al. Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. Blood 101 (2003) 101-103
85. Porter J.B., and Huehns E.R. Transfusion and exchange transfusion in sickle cell anaemias, with particular reference to iron metabolism. Acta Haematol 78 (1987) 198-205
86. Sheehy T.W., Law D.E., and Wade B.H. Exchange transfusion for sickle cell intrahepatic cholestasis. Arch Intern Med 140 (1980) 1364-1365
87. O'Callaghan A., O'Brien S.G., Ninkovic M., et al. Chronic intrahepatic cholestasis in sickle cell disease requiring exchange transfusion. Gut 37 (1995) 144-147
88. Adams D.M., Schultz W.H., Ware R.E., et al. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatr Hematol Oncol 18 (1996) 46-50
89. Vichinsky E., Onyekwere O., Porter J., et al. A randomized comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Hematol 136 (2006) 501-508
90. Voskaridou E., Douskou M., Terpos E., et al. Deferiprone as an oral iron chelator in sickle cell disease. Ann Hematol 84 (2005) 434-440
91. Claster S., and Vichinsky E. First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regeneration. Blood 88 (1996) 1951-1953
92. Bernaudin F. Results and current indications of bone marrow allograft in sickle cell disease. Pathol Biol 47 (1999) 59-64
93. Lerut J.P., Claeys N., Laterre P.F., et al. Hepatic sickling: an unusual cause of liver allograft dysfunction. Transplantation 67 (1999) 65-68
94. Emre S., Schwartz M.E., Shneider B., et al. Living related liver transplantation for acute liver failure in children. Liver Transpl Surg 5 (1999) 161-165
95. Walters M.C., Patience M., Leisenring W., et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 335 (1996) 369-376
96. Hsieh M.M., Kang E.M., Fitzhugh C.D., et al. Allogeneic hemeatopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 361 (2009) 2309-2317
97. Platt O.S., Brambilla D.J., Rosse W.F., et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 330 (1994) 1639-1644
98. Stephan J.L., Merpit-Gonon E., Richard O., et al. Fulminant liver failure in a 12-year-old girl with sickle cell anaemia: favourable outcome after exchange transfusions. Eur J Pediatr 154 (1995) 469-471